In a report published Monday, Deutsche Bank analyst Darren Lehrich upgraded the rating on Laboratory Corp. of America LH from Hold to Buy, and raised the price target from $95.00 to $98.00.
In the report, Deutsche Bank noted, “Everything about LH's 2014 guidance feels kitchen-sinked, thus leaving room for upside surprise if even the slightest things go right. Throw in the possibility of a major cost reduction plan (hinted to on Q4 CC), and we believe LH's margin structure heading into well-anticipated 2015+ Medicare fee schedule cuts could realistically leave LH better positioned vs. expectations.”
Laboratory Corp. of America closed on Friday at $89.15.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in